mepolizumab 100 MG Injection

RxCUI: 1720601
RxNorm name: mepolizumab 100 MG Injection
Display name: mepolizumab 100 MG Injection
Full name: mepolizumab 100 MG Injection
Term type: PSN
Status: DailyMed mapping
Updated: 2026-06-04 23:39:30

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLA	Proprietary name	Proper name	License type	Status	Latest source
125526	Nucala	mepolizumab	351(a)	Rx	2026-07-01
761122	Nucala	mepolizumab	351(a)	Rx	2026-07-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Nucala	MEPOLIZUMAB	GlaxoSmithKline LLC	fefb887c-e4ac-431e-8893-e9d1a5a63fea	2025-08-06	Warnings, Adverse reactions	Exact identifier rxcui: 1720601

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
fefb887c-e4ac-431e-8893-e9d1a5a63fea	mepolizumab 100 MG Injection [PSN] · mepolizumab 100 MG Injection [SCD]	2	24	These highlights do not include all the information needed to use NUCALA safely and effectively. See full prescribing information for NUCALA. NUCALA (mepolizumab) for injection, for subcutaneous use NUCALA (mepolizumab) injection, for subcutaneous use Initial U.S. Approval: 2015	20250806